Nor-Adrenaline (Norepinephrine) – Plasma Test

The Nor-Adrenaline (Norepinephrine) – Plasma test measures the concentration of norepinephrine in a blood plasma sample. Norepinephrine, also called noradrenaline, is a catecholamine that functions as both a hormone and a neurotransmitter. It is produced mainly by sympathetic nerve endings and, to a lesser extent, by the adrenal medulla.

Norepinephrine forms an important part of the body's response to physical or emotional stress. It helps regulate blood pressure, heart rate, blood-vessel tone, alertness and the delivery of blood to vital organs. Its concentration can rise rapidly with changes in posture, exercise, pain, anxiety, low blood sugar, cold exposure and acute illness.

The plasma norepinephrine test may be used as an additional investigation for selected adrenal or neuroendocrine disorders, especially when a catecholamine-producing tumour is suspected. It may also be used in specialised evaluations of autonomic nervous system function. Because norepinephrine changes quickly in response to ordinary physiological stimuli, careful patient preparation and specimen collection are essential.

What Is Norepinephrine?

Norepinephrine belongs to a group of chemical messengers known as catecholamines. The main catecholamines are dopamine, norepinephrine and epinephrine. They are produced through a biochemical pathway that begins with the amino acid tyrosine. Tyrosine is converted to L-DOPA, then dopamine, norepinephrine and finally epinephrine in tissues containing the required enzymes.

The sympathetic nervous system releases norepinephrine when the body needs to respond to stress or maintain blood pressure. Norepinephrine causes many blood vessels to narrow, which helps raise blood pressure. It also affects cardiac function and helps maintain circulation during standing, exercise or other physical demands.

After release, norepinephrine is broken down into metabolites, including normetanephrine and vanillylmandelic acid. These metabolites may remain elevated more consistently than the parent hormone in certain catecholamine-producing tumours. For this reason, plasma free metanephrines or 24-hour urinary fractionated metanephrines are generally preferred as first-line biochemical tests for suspected pheochromocytoma or paraganglioma.

Why Is the Plasma Norepinephrine Test Performed?

A physician, endocrinologist, cardiologist, neurologist or oncologist may request plasma norepinephrine for a particular diagnostic or monitoring purpose. The test may be considered when symptoms suggest excessive catecholamine release, when metanephrine results require further evaluation or when autonomic nervous system dysfunction is being investigated.

Pheochromocytoma and Paraganglioma Evaluation

Pheochromocytoma is a rare tumour arising from catecholamine-producing cells, usually in the adrenal medulla. A similar tumour arising outside the adrenal gland is generally called a paraganglioma. Some of these tumours release excessive norepinephrine, epinephrine or dopamine.

Possible symptoms include episodes of severe or difficult-to-control hypertension, pounding headache, sweating, palpitations, tremors, pallor, anxiety, chest or abdominal discomfort and unexplained spells. Symptoms may be continuous or episodic and can be triggered by physical activity, stress, surgery, certain medicines or changes in pressure around the tumour.

Plasma norepinephrine is not normally the preferred initial screening test because catecholamine release may occur only during a symptomatic spell. Plasma free metanephrines or 24-hour urinary fractionated metanephrines usually provide more sensitive initial testing. Norepinephrine measurement may nevertheless offer additional information when first-line findings are unclear or when a specimen can be collected during symptoms.

Neuroblastoma Assessment

Neuroblastoma is a tumour arising from immature nerve cells and primarily affects infants and children. Some neuroblastomas produce catecholamines or their metabolites. Plasma norepinephrine may contribute to selected investigations, but urinary or plasma catecholamine metabolites such as vanillylmandelic acid and homovanillic acid are generally more established for diagnosis and monitoring.

The evaluation of neuroblastoma also requires clinical assessment, imaging, tumour histopathology, bone marrow studies and molecular or genetic investigations. A plasma norepinephrine result cannot independently diagnose the condition.

Autonomic Nervous System Evaluation

The autonomic nervous system controls involuntary processes such as blood pressure, heart rate, temperature regulation and digestion. Norepinephrine measurements obtained under carefully controlled supine and standing conditions may sometimes contribute to specialised assessment of autonomic failure, orthostatic hypotension or disorders involving sympathetic nervous system activity.

Posture-specific testing requires a defined protocol. Norepinephrine normally increases when a person moves from lying down to standing because the sympathetic nervous system works to maintain blood pressure. Reference intervals differ according to posture, age and collection procedure. Results should therefore be interpreted only by a specialist familiar with the protocol used.

Who May Need This Test?

The test may be considered in patients with recurrent spells of headache, sweating, palpitations and marked hypertension, particularly when a clinician suspects catecholamine excess. It may also be used for selected patients with an adrenal mass, a known hereditary risk for pheochromocytoma or paraganglioma, an inconclusive metanephrine result or symptoms of autonomic dysfunction.

These symptoms have many common causes, including anxiety, thyroid disease, medication effects, heart-rhythm disorders and essential hypertension. Norepinephrine testing should be requested after medical evaluation rather than used as a general health or cancer screening test.

Sample Requirements

The test requires plasma obtained from venous blood. A specialised collection tube, commonly containing EDTA or another laboratory-specified anticoagulant, may be required. The plasma often needs to be separated promptly and transported under controlled temperature conditions.

Patients and collection staff should confirm the required tube, sample volume, posture, resting period, processing procedure and storage instructions before collection. Catecholamines can be affected by delayed separation or inappropriate handling.

Patient Preparation

Preparation requirements vary according to the laboratory and reason for testing. The patient may be instructed to rest quietly in a supine position for approximately 20 to 30 minutes before blood collection. A calm environment is important because anxiety, pain and difficult venepuncture may increase catecholamine release.

Strenuous exercise should generally be avoided before testing. The laboratory or doctor may also advise avoiding caffeine, nicotine, alcohol and selected foods for a specified period. Requirements should be confirmed directly because protocols differ.

Many prescription, non-prescription and recreational substances can affect norepinephrine concentrations or interfere with measurement. These may include sympathomimetics, decongestants, stimulant medicines, antidepressants, levodopa, some blood-pressure medicines, nicotine and caffeine. Withdrawal from certain medicines or substances can also cause rebound catecholamine release.

Patients must provide a complete list of medicines and supplements to their doctor. No medicine should be stopped without medical supervision. If stopping treatment is unsafe, the doctor and laboratory can consider the possible effect during interpretation.

Posture and Resting Conditions

Posture significantly influences norepinephrine. Concentrations are generally lower when a person has been resting while lying down and higher after sitting or standing. Therefore, the reference interval must correspond to the patient's position at collection.

The requisition or specimen record should document whether the sample was collected while supine, seated or standing and how long the patient remained in that position. Comparing a standing result with a supine reference interval may lead to incorrect interpretation.

Collection During a Symptomatic Spell

When a clinician specifically requests plasma catecholamines for suspected episodic secretion, collection during a characteristic spell may improve the chance of identifying an increase. However, a symptomatic episode involving severe hypertension, chest pain, breathing difficulty, fainting or neurological symptoms requires immediate medical evaluation. Testing must not delay emergency treatment.

How Is Plasma Norepinephrine Measured?

The laboratory may measure norepinephrine using high-performance liquid chromatography, electrochemical detection or liquid chromatography–tandem mass spectrometry. The method separates norepinephrine from other catecholamines and interfering compounds before measuring its concentration.

The report provides a value with a method-specific and often posture-specific reference interval. Different laboratories may use different instruments, calibrators and units. Results should not be compared directly unless the same method and collection conditions were used.

Understanding the Results

The norepinephrine result must be interpreted according to symptoms, collection posture, resting time, medicines, stress level, kidney function and other laboratory findings. An isolated mild increase is frequently caused by physiological stress, medication or improper preparation rather than a tumour.

Elevated Plasma Norepinephrine

An increased concentration may occur with a norepinephrine-producing pheochromocytoma or paraganglioma. It may also be associated with neuroblastoma, severe physiological stress, acute illness, pain, hypoglycaemia, strenuous exercise, anxiety or certain autonomic disorders.

Small increases, particularly values less than approximately twice the method-specific upper reference limit, are often related to posture, stress, medication or collection conditions. A significant elevation requires clinical review but still does not independently confirm a tumour.

The doctor may recommend plasma free metanephrines, 24-hour urinary fractionated metanephrines, repeat testing under controlled conditions or imaging when biochemical evidence is convincing. Imaging is generally performed after appropriate biochemical evaluation rather than solely because of one mildly elevated norepinephrine result.

Normal Plasma Norepinephrine

A normal value does not completely exclude pheochromocytoma or paraganglioma because catecholamine secretion may be intermittent. A sample collected between spells may be normal even when a tumour is present. Metanephrines are usually more continuously produced and are preferred for initial biochemical screening.

When the test is used for autonomic evaluation, a low or inadequate increase after standing may require specialist interpretation. It cannot independently identify the cause of orthostatic symptoms.

Low Plasma Norepinephrine

A low concentration may occur in selected forms of autonomic failure or rare disorders affecting catecholamine synthesis, such as dopamine beta-hydroxylase deficiency. It may also be influenced by medicines, posture and collection conditions. A low value is not diagnostic without an appropriate clinical and autonomic assessment.

Additional Tests That May Be Recommended

Depending on the indication and initial result, the doctor may recommend:

• Plasma free fractionated metanephrines.
• Twenty-four-hour urinary fractionated metanephrines.
• Plasma or urine epinephrine and dopamine measurements.
• Urinary vanillylmandelic acid and homovanillic acid.
• Chromogranin A in selected clinical circumstances.
• Blood pressure and heart-rate testing while supine and standing.
• CT or MRI after appropriate biochemical assessment.
• Functional imaging for selected confirmed or strongly suspected tumours.
• Genetic counselling and testing when hereditary disease is suspected.

The choice of additional tests depends on the patient's age, symptoms, medical history and biochemical findings.

Benefits and Limitations

Plasma norepinephrine measurement provides direct information about circulating norepinephrine at the time of collection. It may be valuable during a characteristic spell or as part of a carefully designed autonomic study. It can also complement metanephrine testing in selected complex cases.

The principal limitation is substantial biological variability. Stress, pain, posture, exercise, food, caffeine, nicotine, alcohol, medicines and specimen handling can alter the result. Catecholamine-producing tumours may also release hormones intermittently, reducing the sensitivity of a single sample.

The test should not replace plasma free or urinary fractionated metanephrines as the usual first-line investigation for pheochromocytoma or paraganglioma. Results require specialist interpretation and clinical correlation.

Plasma Nor-Adrenaline Test at Focus Diagnostics

The NOR-ADRENALINE (NOR- EPINEPHRINE) - PLASMA test is available under the pathology and bio-chemistry department at a listed price of ₹3,250. Patients should confirm preparation, posture, collection timing, tube type and expected reporting time before visiting the diagnostic centre.

Bring the doctor's prescription and a complete medicine and supplement list. If serial monitoring is required, consistent preparation, posture and testing methodology improve the value of comparisons.

Important Patient Instructions

• Rest as directed before the sample is collected.
• Avoid strenuous exercise and other restricted substances according to laboratory instructions.
• Inform the doctor about all medicines, supplements and substance withdrawal.
• Do not stop prescribed medicine without medical supervision.
• Discuss the result with the requesting doctor.

Medical Disclaimer

This information is provided for general education and does not replace medical consultation. Plasma norepinephrine cannot independently diagnose or exclude pheochromocytoma, paraganglioma, neuroblastoma or autonomic disease. Results must be evaluated with clinical findings and other appropriate investigations.